2023 Q4 Form 10-Q Financial Statement

#000143774923031965 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue $60.00K $61.00K $2.000K
YoY Change 2900.0% 2950.0% 100.0%
Gross Profit -$60.00K -$61.00K -$2.000K
YoY Change -106.5% 2950.0% -101.4%
Gross Profit Margin
Selling, General & Admin $630.0K $904.0K $1.678M
YoY Change -74.9% -46.13% -17.09%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $56.00K $70.00K $75.00K
YoY Change -23.29% -6.67% -16.67%
% of Gross Profit
Operating Expenses $630.0K $904.0K $1.678M
YoY Change -74.9% -46.13% -17.09%
Operating Profit -$690.0K -$965.0K -$1.680M
YoY Change -56.52% -42.56% -10.69%
Interest Expense -$75.00K $107.0K $95.00K
YoY Change -1.32% 12.63% 35.71%
% of Operating Profit
Other Income/Expense, Net -$345.0K -$2.958M $1.278M
YoY Change -90.63% -331.46% -673.09%
Pretax Income -$1.110M -$3.920M -$402.0K
YoY Change -79.23% 875.12% -80.89%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.110M -$3.923M -$402.0K
YoY Change -79.23% 875.87% -80.89%
Net Earnings / Revenue
Basic Earnings Per Share -$0.05 -$0.01
Diluted Earnings Per Share -$0.01 -$0.05 -$5.118K
COMMON SHARES
Basic Shares Outstanding 87.51M 86.42M 78.54M
Diluted Shares Outstanding 86.33M 78.54M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.560M $3.330M $333.0K
YoY Change 2248.62% 900.0% -56.18%
Cash & Equivalents $2.600M $3.300M $300.0K
Short-Term Investments
Other Short-Term Assets $34.00K $37.00K $14.00K
YoY Change 13.33% 164.29% -22.22%
Inventory
Prepaid Expenses $61.00K $81.00K $284.0K
Receivables
Other Receivables
Total Short-Term Assets $2.655M $3.451M $631.0K
YoY Change 593.21% 446.91% -57.51%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000K
YoY Change -76.19%
Goodwill
YoY Change
Intangibles $1.055M $1.130M $1.490M
YoY Change -22.37% -24.16% -21.04%
Long-Term Investments
YoY Change
Other Assets $313.0K $3.000K $18.00K
YoY Change 6160.0% -83.33%
Total Long-Term Assets $1.368M $1.133M $1.513M
YoY Change 0.0% -25.12% -21.03%
TOTAL ASSETS
Total Short-Term Assets $2.655M $3.451M $631.0K
Total Long-Term Assets $1.368M $1.133M $1.513M
Total Assets $4.023M $4.584M $2.144M
YoY Change 129.75% 113.81% -36.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $573.0K $796.0K $828.0K
YoY Change -36.4% -3.86% 40.58%
Accrued Expenses $537.0K $580.0K $693.0K
YoY Change -9.29% -16.31% -14.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.179M $1.180M $752.0K
YoY Change 54.32% 56.91% 630.1%
Total Short-Term Liabilities $2.289M $2.552M $2.273M
YoY Change 1.42% 12.27% 51.53%
LONG-TERM LIABILITIES
Long-Term Debt $41.25M $11.95M $9.099M
YoY Change 335.39% 31.33% -3.15%
Other Long-Term Liabilities $28.99M $37.44M
YoY Change -22.56% 3743500.0%
Total Long-Term Liabilities $41.25M $40.94M $46.54M
YoY Change -17.79% -12.02% 2.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.289M $2.552M $2.273M
Total Long-Term Liabilities $41.25M $40.94M $46.54M
Total Liabilities $43.54M $43.49M $48.81M
YoY Change -16.97% -10.89% 4.13%
SHAREHOLDERS EQUITY
Retained Earnings -$433.7M -$432.6M -$437.9M
YoY Change -2.14% -1.21% 1.81%
Common Stock $877.0K $868.0K $788.0K
YoY Change 8.0% 10.15% -99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.52M -$38.91M -$46.66M
YoY Change
Total Liabilities & Shareholders Equity $4.023M $4.584M $2.144M
YoY Change 129.75% 113.81% -36.96%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$1.110M -$3.923M -$402.0K
YoY Change -79.23% 875.87% -80.89%
Depreciation, Depletion And Amortization $56.00K $70.00K $75.00K
YoY Change -23.29% -6.67% -16.67%
Cash From Operating Activities -$739.0K -$740.0K -$747.0K
YoY Change 22.55% -0.94% -8.79%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.000K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -28.00K -140.0K 234.0K
YoY Change -107.39% -159.83% 154.35%
NET CHANGE
Cash From Operating Activities -739.0K -740.0K -747.0K
Cash From Investing Activities -2.000K 0.000 0.000
Cash From Financing Activities -28.00K -140.0K 234.0K
Net Change In Cash -769.0K -880.0K -513.0K
YoY Change 243.3% 71.54% -29.44%
FREE CASH FLOW
Cash From Operating Activities -$739.0K -$740.0K -$747.0K
Capital Expenditures $2.000K $0.00 $0.00
Free Cash Flow -$741.0K -$740.0K -$747.0K
YoY Change 22.89% -0.94% -8.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86761000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86761000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81246000
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81246000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-22904
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2971472
dei Entity Address Address Line1
EntityAddressAddressLine1
4446-1A Hendricks Avenue, Suite 354
dei Entity Address City Or Town
EntityAddressCityOrTown
Jacksonville
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32207
dei City Area Code
CityAreaCode
904
dei Local Phone Number
LocalPhoneNumber
732-6100
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87510563
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3333000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
81000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
244000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
37000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
30000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
3451000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
383000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1130000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1359000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9000 usd
CY2023Q3 us-gaap Assets
Assets
4584000 usd
CY2022Q4 us-gaap Assets
Assets
1751000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
796000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
901000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
47000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
23000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
82000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
79000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
450000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
490000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
132000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
139000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1045000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
625000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2552000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2257000 usd
CY2023Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
28993000 usd
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
40708000 usd
CY2023Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
7682000 usd
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
5089000 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3893000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3913000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
374000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
473000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
40942000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
50183000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
43494000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
52440000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
868000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
812000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
392822000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
391724000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-432600000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-443225000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-38910000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-50689000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4584000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1751000 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
25000000 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
61000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
2000 usd
us-gaap Cost Of Revenue
CostOfRevenue
167000 usd
us-gaap Cost Of Revenue
CostOfRevenue
8000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-61000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-2000 usd
us-gaap Gross Profit
GrossProfit
24833000 usd
us-gaap Gross Profit
GrossProfit
-8000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
904000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1678000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14114000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5263000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
904000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1678000 usd
us-gaap Operating Expenses
OperatingExpenses
14114000 usd
us-gaap Operating Expenses
OperatingExpenses
5263000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
29000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
28000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
29000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
84000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
107000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
95000 usd
us-gaap Interest Expense
InterestExpense
320000 usd
us-gaap Interest Expense
InterestExpense
229000 usd
CY2023Q3 prkr Gain Loss Contingent Payment Obligation
GainLossContingentPaymentObligation
-2880000 usd
CY2022Q3 prkr Gain Loss Contingent Payment Obligation
GainLossContingentPaymentObligation
1345000 usd
prkr Gain Loss Contingent Payment Obligation
GainLossContingentPaymentObligation
197000 usd
prkr Gain Loss Contingent Payment Obligation
GainLossContingentPaymentObligation
948000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2958000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1278000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-94000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
803000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3923000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-402000 usd
us-gaap Net Income Loss
NetIncomeLoss
10625000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4468000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3923000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-402000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10625000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4468000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86330000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78542000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85163000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78025000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86330000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78542000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119558000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78025000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-35204000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-47149000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-50689000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-44777000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-38910000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-46664000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-38910000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-46664000 usd
us-gaap Net Income Loss
NetIncomeLoss
10625000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4468000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
195000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
238000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
408000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2295000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-197000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-948000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-41000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-64000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-283000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-327000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
176000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
136000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
906000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
2112000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11531000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2356000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000 usd
prkr Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights
ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights
121000 usd
prkr Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights
ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights
-18000 usd
prkr Proceeds From Warrant And Stock Option Exercised
ProceedsFromWarrantAndStockOptionExercised
4000 usd
prkr Proceeds From Warrant And Stock Option Exercised
ProceedsFromWarrantAndStockOptionExercised
83000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8306000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1663000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3224000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-697000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1030000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3333000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
25000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
25000 usd
CY2023Q3 prkr Prepaid Licenses Software Tools And Support
PrepaidLicensesSoftwareToolsAndSupport
10000 usd
CY2022Q4 prkr Prepaid Licenses Software Tools And Support
PrepaidLicensesSoftwareToolsAndSupport
15000 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">1.</em> Description of Business</b></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH (collectively “ParkerVision”, “we” or the “Company”), is in the business of innovating fundamental wireless hardware technologies and products.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">We have designed and developed proprietary radio frequency (“RF”) technologies and integrated circuits based on those technologies, and we license those technologies to others for use in wireless communication products.  We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions.  We believe certain patents protecting our proprietary technologies have been broadly infringed by others, and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent licensing and infringement litigation efforts.  We currently have patent enforcement actions ongoing in various U.S. district courts against mobile handset, smart television and other WiFi product providers, as well as semiconductor suppliers, for the infringement of a number of our RF patents.  We have made significant investments in developing and protecting our technologies.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p>
us-gaap Net Income Loss
NetIncomeLoss
10600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11500000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
100000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
200000 usd
prkr Proceeds From Issuance Of Debt And Equity
ProceedsFromIssuanceOfDebtAndEquity
900000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3300000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-432600000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1050000.00 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">3.</em> Basis of Presentation </b></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The accompanying unaudited condensed consolidated financial statements for the period ended <em style="font: inherit;"> September 30, 2023</em> were prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form <em style="font: inherit;">10</em>-Q and Rule <em style="font: inherit;">10</em>-<em style="font: inherit;">01</em> of Regulation S-<em style="font: inherit;">X.</em>  Operating results for the <em class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2023</em>, are <em style="font: inherit;">not</em> necessarily indicative of the results that <em style="font: inherit;"> may </em>be expected for the year ending <em style="font: inherit;"> December 31, 2023</em>, or future years.  All normal and recurring adjustments which, in the opinion of management, are necessary for a fair statement of the consolidated financial condition and results of operations have been included.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The year-end condensed consolidated balance sheet data was derived from audited financial statements for the year ended <em style="font: inherit;"> December 31, 2022</em>.  Certain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with GAAP have been omitted from these interim condensed consolidated financial statements.  These interim condensed consolidated financial statements should be read in conjunction with our latest Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2022</em> (“<em style="font: inherit;">2022</em> Annual Report”).  Certain reclassifications have been made to prior period amounts to conform to the current period presentation.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The condensed consolidated financial statements include the accounts of ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH, after elimination of all intercompany transactions and accounts.  </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -18pt;"> </p>
us-gaap Net Income Loss
NetIncomeLoss
10625000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4468000 usd
prkr Income Attributable To The Dilutive Securities If Converted Or Exercised
IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised
302000 usd
prkr Income Attributable To The Dilutive Securities If Converted Or Exercised
IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised
0 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
10927000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-4468000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85163000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78025000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
34395000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119558000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78025000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72305000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66660000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35880000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66660000
CY2023Q3 prkr Prepaid Services
PrepaidServices
37000 usd
CY2022Q4 prkr Prepaid Services
PrepaidServices
202000 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
32000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
81000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
244000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10517000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14319000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9387000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12960000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1130000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1359000 usd
CY2023Q3 us-gaap Convertible Debt
ConvertibleDebt
4938000 usd
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
4538000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1045000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
625000 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3893000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3913000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10300000
prkr Class Of Warrant Or Right Weighted Average Remaining Life
ClassOfWarrantOrRightWeightedAverageRemainingLife
P1Y3M18D
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
100000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y7M6D
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure

Files In Submission

Name View Source Status
0001437749-23-031965-index-headers.html Edgar Link pending
0001437749-23-031965-index.html Edgar Link pending
0001437749-23-031965.txt Edgar Link pending
0001437749-23-031965-xbrl.zip Edgar Link pending
ex_567964.htm Edgar Link pending
ex_567965.htm Edgar Link pending
ex_567966.htm Edgar Link pending
ex_587932.htm Edgar Link pending
ex_587933.htm Edgar Link pending
prkr-20230930_lab.xml Edgar Link unprocessable
prkr-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
prkr-20230930.xsd Edgar Link pending
prkr20230930c_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
prkr-20230930_cal.xml Edgar Link unprocessable
prkr-20230930_pre.xml Edgar Link unprocessable
prkr20230930c_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending